Form 4: Phreesia SVP, Life Sciences, David Linetsky, Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
David Linetsky, SVP of Life Sciences at Phreesia, Inc., sold shares to cover tax obligations related to the settlement of restricted stock units.
Summary
- David Linetsky, a Senior Vice President at Phreesia, Inc., sold a total of 94 shares of common stock across three transactions on December 16th and 17th, 2024.
- These sales were executed to cover tax withholding obligations associated with the settlement of restricted stock units.
- The shares were sold at weighted average prices, with individual transaction prices ranging from $24.415 to $25.915 per share.
- Following these transactions, Mr. Linetsky's spouse indirectly holds 8,875 shares of common stock, and Mr. Linetsky directly holds 188,354 shares.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction for tax purposes and does not indicate any positive or negative sentiment towards the company's performance or future prospects.
Industry Context
This is a routine filing related to insider transactions and is common for executives who receive stock-based compensation. It does not indicate any specific trend or issue within the company or the broader industry.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in the US, and the transactions reported are typical for executives managing their stock-based compensation.
- Similar filings are regularly seen across the technology and healthcare sectors, where stock options and restricted stock units are common forms of compensation.
- The sale of shares to cover tax obligations is a common practice and does not indicate any unusual activity compared to other companies.
Stakeholder Impact
- The transactions have a minimal impact on shareholders as they are routine sales by an executive to cover tax obligations.
- The sales do not indicate any change in the company's operations or financial health.
Key Dates
| Date | Description |
|---|---|
| 12/16/2024 | Date of the first reported stock sale. |
| 12/17/2024 | Date of the second and third reported stock sales. |
| 12/18/2024 | Date the Form 4 was signed. |
Keywords
Phreesia, insider trading, Form 4, stock sale, David Linetsky, restricted stock units, tax obligations, share disposal
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.